Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

NCT06254326 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT06254326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06254326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Lead sponsor
University of Florida
Phase
Phase 1
Overall status
Recruiting
Start date
September 19, 2024
Completion date
June 30, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progressive oligodendroglioma, recurrent oligodendroglioma